Blood Diagnostics

Tamanaha_Takashi shared “森友問題 自殺職員の妻が訴え「菅さん逃げないで」|テレ朝news” | 9/20/2020

… achieve Unicorn status Research from New York Data Analytics firm CB Insights revealed the Arab world has just one single Unicorn Read more at Twitter DrEddyClinic 🇩🇪 and 1 other shared dreddymd.com Dark field blood diagnostics Dark field blood diagnostics is a Method of Professor Dr. Guenther Enderlein (1872-1968), that primarily a biologist … Read more at Twitter DrEddyClinic 🇩🇪 and 1 other shared dreddymd.com 10 Best Herbs for Boosting Female …

Sight Diagnostics Gets $71 Million in Series D Funding | 9/11/2020

Shopping for Healthcare In a confirmation of its standing and potential in the blood diagnostics industry and its new flagship blood analysis product, Sight Diagnostics the company that developed and manufactured the first FDA-approved finger stick Complete Blood Count analyzer has raised $71 million dollars in its series D round of funding. Sight Diagnostics has become a market leader by developing an exciting blood diagnostics device that cuts the …

Follow Blood Diagnostics:    

COVAXX Synthetic Multitope Vaccine Selected for Human Trials in Brazil by Dasa, the Largest Diagnostic Company, and Mafra the Leading Private Vaccine Distributor | PR Newswire | 9/9/2020

… arms. UB-612 is designed to mimic natural biology and preclinical studies have shown very high immunogenicity and levels of neutralizing titers against SARS-CoV-2. The technology platform has been successful in commercializing blood diagnostics as well as safe and effective vaccines for infectious disease in animal health and has been tested in numerous clinical trials for other indications to date. “This donation is aligned with other efforts from …

PRESS RELEASE: Sight Diagnostics Raises $71M To Accelerate Global Expansion of itsFDA 510(k) Cleared, CE Marked Finger-prick Blood Analyzer | 8/6/2020

… vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, President of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” Founded in 2011, Sight Diagnostics aims to transform blood testing through its flagship Sight …

Sight Diagnostics raises $71M Series D for its blood analyzer | TechCrunch | 8/5/2020

… gather the data to detect anomalies that may indicate the severity of some of the aspects of the disease. “We just kind of scratched the surface of the ability of AI to help with blood diagnostics ,” said Pollak. “Specifically now, there’s so much value around COVID in decentralizing diagnostics and blood tests. Think keeping people — COVID-negative or -positive — outside of hospitals to reduce the busyness of hospitals and reduce …

Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach | FierceBiotech | 8/5/2020

… vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, president of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” RELATED: Tabletop blood count developer Sight raises $27.8M in series C round The cartridge …

Blood Diagnostics Firm Sight Raises $71M For System That Produces Quick Results | 8/5/2020

… vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, President of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world …

Sight Diagnostics hauls in $71M Series D for point-of-care blood analysis | MobiHealthNews | 8/5/2020

… roughly $28 billion by 2026 with a CAGR of 6.6%. It cited advancing tech and the rising awareness of point-of-care diagnostics as key drivers of that growth. Sight’s approach of AI-based blood diagnostics runs parallel to that of 1Drop Diagnostics. This startup, which raised $4.25 million in late 2018 , measures biomarkers from a single drop of blood and delivers a response within roughly 15 minutes via its …

Finger-Prick Blood Analyzer Company Raises $71M | 8/5/2020

… vision to analyze blood is a significant leap forward from the current alternative in healthcare,” said Chase Koch, president of Koch Disruptive Technologies. “Not only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” Founded in 2011, Sight Diagnostics aims to transform blood testing through its flagship Sight …

Sight Diagnostics hauls in $71M Series D for fingerprick blood analysis | MobiHealthNews | 8/5/2020

… roughly $28 billion by 2026 with a CAGR of 6.6%. It cited advancing tech and the rising awareness of point-of-care diagnostics as key drivers of that growth. Sight’s approach of AI-based blood diagnostics runs parallel to that of 1Drop Diagnostics. This startup, which raised $4.25 million in late 2018 , measures biomarkers from a single drop of blood and delivers a response within roughly 15 minutes via its …

Workpath Announces 105% Customer Count Growth from Q1 to Q2; Annual Revenue Growth of 50% | PR Newswire | 7/22/2020

RICHMOND, Va. , July 22, Workpath, the only on-demand dispatch and scheduling tech for mobile healthcare teams, is proud to announce a 105% increase in the company’s customer count and a 50% increase in revenue from Q1 to Q2 2020. Platform usage has surged as well. Weekly appointment volume increased 165% since January when the first COVID-19 case was reported in the U.S. Since the launch of the platform …

Better Coronavirus Stock: Grifols or Novartis? | The Motley Fool | 6/19/2020

… company warrants investment? Image source: Getty Images. Grifols takes aim at the COVID-19 plasma therapeutics market Grifols has a lot to offer investors seeking steady growth. With a stable of products ranging from blood diagnostics to infusion-ready IV nutrition bags, the company competes in a handful of different markets, and its pipeline features seven different projects in clinical development. Considering its 11.8% year-over-year revenue growth, Grifols …

Report Study | Impact of COVID-19 on the Global Blood Transfusion Diagnostics Market | 6/8/2020

The new market report on Blood Transfusion Diagnostics is a comprehensive study providing analysis on factors trend and drivers contributing to growth of the Blood Diagnostics . The report is prepared with reference to historic data . Estimation of contribution of segment is expressed in terms of volume and revenue for the forecast period . Market analysis and future prospect is segmented in various sections. Each sections focus on distinct features of the …

5 Reasons to Consider an Alternative to Linux for Your Medical Device | 4/9/2020

… of developers, a rich legacy of source code, and industry-standard POSIX APIs. But Linux may not be the right choice for all projects, especially safety-critical medical devices such as those used in blood diagnostics , ultrasound imaging, infusion delivery, heart monitoring and resuscitation, and robotic surgery. For these demanding applications, the standard Linux kernel can’t deliver the safety-critical capabilities that many medical embedded devices require. While Linux may …

New Matternet Docking Station Unveiled | 3/12/2020

… automated drone delivery into their laboratory and pharmacy operations. The company has been operating in healthcare systems around the world since 2017, replacing slow and expensive on-demand courier services. Hospitals can now move blood diagnostics , pathology specimens and medicine between their facilities and suppliers with secure, extremely fast and predictable aerial delivery. “Our vision is to connect every healthcare facility in every metropolitan area with the fastest transportation method …

Matternet Unveils New Matternet Station | 3/11/2020

… automated drone delivery into their laboratory and pharmacy operations. The company has been operating in healthcare systems around the world since 2017, replacing slow and expensive on-demand courier services. Hospitals can now move blood diagnostics , pathology specimens and medicine between their facilities and suppliers with secure, extremely fast and predictable aerial delivery. “Our vision is to connect every healthcare facility in every metropolitan area with the fastest transportation method …

Matternet Station to serve as drone delivery hub for hospitals | 3/11/2020

… controlled temperature Matternet The striking Mattenet Station serves as a drone delivery hub for medical packages Matternet 6 / 7 Matternet expects the service to operate around the clock and accommodate the safe transport of blood diagnostics , pathology specimens and medicine Matternet The Matternet Station will serve as a delivery hub for the company’s M2 autonomous drone Matternet View gallery - 7 images Last year, drone logistics company Matternet teamed up with …

Matternet Unveils The New Matternet Station | 3/11/2020

… automated drone delivery into their laboratory and pharmacy operations. The company has been operating in healthcare systems around the world since 2017, replacing slow and expensive on-demand courier services. Hospitals can now move blood diagnostics , pathology specimens and medicine between their facilities and suppliers with secure, extremely fast and predictable aerial delivery. “Our vision is to connect every healthcare facility in every metropolitan area with the fastest transportation method …

Matternet Unveils the New Matternet Station | PR Newswire | 3/10/2020

… automated drone delivery into their laboratory and pharmacy operations. The company has been operating in healthcare systems around the world since 2017, replacing slow and expensive on-demand courier services. Hospitals can now move blood diagnostics , pathology specimens and medicine between their facilities and suppliers with secure, extremely fast and predictable aerial delivery. “Our vision is to connect every healthcare facility in every metropolitan area with the fastest transportation method …

Matternet Unveils the New Matternet Station | 3/10/2020

… automated drone delivery into their laboratory and pharmacy operations. The company has been operating in healthcare systems around the world since 2017, replacing slow and expensive on-demand courier services. Hospitals can now move blood diagnostics , pathology specimens and medicine between their facilities and suppliers with secure, extremely fast and predictable aerial delivery. “Our vision is to connect every healthcare facility in every metropolitan area with the fastest transportation method …

Eisai to Present Latest Data on Alzheimer’s Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer’s Disease Conference | BioSpace | 12/4/2019

… Alzheimer’s Disease (CTAD) conference taking place in San Diego, California in the United States, from December 4 to 7, 2019. BAN2401 is being jointly developed by Eisai and Biogen Inc. In addition, the simple blood diagnostics for AD are being jointly developing by Eisai and Sysmex Corporation. For BAN2401, the persistance of brain Abeta levels in patients with early AD at the beginning of the open label extension phase of …

Eisai to Present Latest Data on Alzheimer’s Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer’s Disease Conference | 12/2/2019

… Alzheimer’s Disease (CTAD) conference taking place in San Diego, California in the United States, from December 4 to 7, 2019. BAN2401 is being jointly developed by Eisai and Biogen Inc. In addition, the simple blood diagnostics for AD are being jointly developing by Eisai and Sysmex Corporation.For BAN2401, the persistance of brain Abeta levels in patients with early AD at the beginning of the open label extension phase of the …

Eisai to Present Latest Data on Alzheimer’s Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer’s Disease Conference | 12/2/2019

… Alzheimer’s Disease (CTAD) conference taking place in San Diego, California in the United States, from December 4 to 7, 2019. BAN2401 is being jointly developed by Eisai and Biogen Inc. In addition, the simple blood diagnostics for AD are being jointly developing by Eisai and Sysmex Corporation. For BAN2401, the persistance of brain Abeta levels in patients with early AD at the beginning of the open label extension phase of …

Eisai to Present Latest Data on Alzheimer’s Disease / Dementia Pipeline at 12th Clinical Trials on Alzheimer’s Disease Conference | 12/2/2019

… Alzheimer’s Disease (CTAD) conference taking place in San Diego, California in the United States, from December 4 to 7, 2019. BAN2401 is being jointly developed by Eisai and Biogen Inc. In addition, the simple blood diagnostics for AD are being jointly developing by Eisai and Sysmex Corporation. For BAN2401, the persistance of brain Abeta levels in patients with early AD at the beginning of the open label extension phase of …

T2 Biosystems to Share Early Data at the World Anti-Microbial Resistance Congress (November 7-8, 2019) | Globe Newswire | 11/7/2019

Data will focus on the first RUO assay that can detect 13 resistance genes from both gram-positive and gram-negative pathogens directly from whole blood November 07, 2019 07:30 ET Source: T2 Biosystems, Inc. LEXINGTON, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) – T2 Biosystems, Inc. (NASDAQ: TTOO ), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will be highlighting its …